Influence of infection and α1-proteinase inhibitor on inflammatory response in COPD exacerbation Source: Eur Respir J 2003; 22: Suppl. 45, 417s Year: 2003
A point of care neutrophil elastase activity assay identifies bronchiectasis severity, airway infection and risk of exacerbation Source: International Congress 2019 – Advances in bronchiectasis and non-TB mycobacterial infections Year: 2019
A point-of-care neutrophil elastase activity assay identifies bronchiectasis severity, airway infection and risk of exacerbation Source: Eur Respir J, 53 (6) 1900303; 10.1183/13993003.00303-2019 Year: 2019
Proteinase 3 activity in sputum from subjects with alpha-1-antitrypsin deficiency and COPD Source: Eur Respir J 2013; 41: 1042-1050 Year: 2013
Neutrophil extracellular traps (NETs) in COPD: A potential novel mechanism for host damage in acute exacerbations Source: International Congress 2015 – Cellular and molecular mechanisms of COPD and emphysema Year: 2015
Inflammatory markers and HDAC activity in induced sputum of smokers and COPD patients Source: Eur Respir J 2007; 30: Suppl. 51, 586s Year: 2007
COPD exacerbation severity is associated with impaired macrophage phagocytosis of eosinophils Source: Annual Congress 2013 –Cell biology and murine models of asthma and inflammation Year: 2013
Low-dose theophylline improves lung inflammatory profile during COPD exacerbations by increasing histone deacetylase activity Source: Annual Congress 2008 - Recent advances in the pathogenesis and treatment of asthma and COPD Year: 2008
Bacterial infection, IL-8 and elastase activity in children with chronic bronchiolitis and bronchial asthma in stable period Source: Eur Respir J 2003; 22: Suppl. 45, 516s Year: 2003
Measurement of in situ inflammatory cell activity in the lungs of patients with COPD or asthma Source: Eur Respir J 2002; 20: Suppl. 38, 267s Year: 2002
A?-Val360: a marker of neutrophil elastase and COPD disease activity Source: Eur Respir J 2013; 41: 31-38 Year: 2013
Neutrophil elastase in severe COPD and asthma exacerbation Source: Eur Respir J 2006; 28: Suppl. 50, 36s Year: 2006
Type of infection and inflammatory activity at COPD Source: Eur Respir J 2004; 24: Suppl. 48, 409s Year: 2004
Monocytes phagocytosis activity during remission and exacerbation of COPD Source: Eur Respir J 2006; 28: Suppl. 50, 33s Year: 2006
Monitoring antioxidant enzyme activity in patients with COPD exacerbations Source: International Congress 2018 – Clinical determinants and biomarkers of COPD Year: 2018
Antimicrobial susceptibility of neutrophil elastase activity (NEA) in elderly patients with COPD's new acute phase Source: Eur Respir J 2002; 20: Suppl. 38, 282s Year: 2002
Protease anti-protease imbalance and small airways disease in COPD Source: International Congress 2018 – COPD: novel pathological mechanisms in the airway epithelium Year: 2018
LATE-BREAKING ABSTRACT: The histone-deacetylase-8 selective inhibitor PCI-34051 enhances IFN-λ production in vitro and reduces inflammation in mouse models of rhinoviral infection and rhinovirus-induced exacerbations of asthma in vivo Source: Annual Congress 2013 –Hot topics on airway diseases: new horizons in treatment Year: 2013
Lung function in patients with different infecting agents caused acute exacerbation of COPD Source: Eur Respir J 2003; 22: Suppl. 45, 337s Year: 2003
Altered expression of glycosaminoglycans in the BAL of COPD patients with acute exacerbation Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench Year: 2013